|
市場調査レポート
画像診断市場：最近の進化と将来動向
Diagnostic Imaging Market: Recent Advances and Future Trends
|
Abstract
Introduction
Scientific and technological developments are making the fi eld of diagnostic
imaging a growth industry. In 2007, the U.S. market for diagnostic imaging
technologies was valued at more than $7 billion, and it is expected to exceed
$8 billion by 2011. There are several trends that companies must heed to enjoy
success in this market.
Get the Answers You Need to Shape Your Strategy
- Diagnostic imaging comprises fi ve major modalities: magnetic resonance
imaging (MRI), ultrasound, X ray, computed tomography (CT), and nuclear
medicine (i.e., single-photon-emission-computed tomography [SPECT] and
positron-emission tomography [PET]). What is the value of each of these fi
elds today, and what are their growth prospects through 2011?
- Opportunities for growth in the industry are varied. One area is the
development of hybrid modalities to combat competition and provide a more
comprehensive and accurate diagnostic image. What hybrids have been developed,
and which ones are still at the development stage? What are their respective
advantages in the clinic?
- The diagnostic imaging market faces two key challenges. What are these
challenges, and how might the industry address them?
Scope
- The major diagnostic imaging modalities: magnetic resonance imaging (MRI),
ultrasound, X ray, computed tomography (CT), and nuclear medicine (i.e.,
single-photon-emission-computed tomography [SPECT] and positron-emission
tomography [PET]).
- Opportunities for industry growth: improving clinical applications,
developing hybrid modalities, advances in information technology, and
exploiting nanotechnology.
- The top three companies in the diagnostic imaging market: GE Healthcare,
Siemens Healthcare Solutions, and Philips Medical Systems.
Companies Mentioned in This Spectrum Report
- Agfa Healthcare
- Bracco Diagnostics
- Commissure
- DR Systems
- Fujifi lm Medical Systems
- GE Healthcare
- General Electric Company
- Hitachi Medical Systems
- ImaRx Therapeutics
- Kodak Health Group
- Kereos
- Mallinckrodt
- Medipattern
- Philips Medical Systems
- Scottsdale Medical Imaging
- Siemens Healthcare Solutions
- Toshiba America Medical Systems
Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview of the Diagnostic Imaging Market
- Key Diagnostic Imaging Technologies
- X Ray
- Computed Tomography
- Magnetic Resonance Imaging
- Nuclear Medicine Imaging
- Single-Photon-Electron-Computed Tomography
- Positron-Emission Tomography
- Ultrasound
- Opportunities for Industry Growth
- Improving Clinical Applications
- Developing Hybrid Modalities
- Improving Imaging Agents
- Advances in Information Technology
- Picture Archiving and Communication System
- Computer-Aided Detection/Diagnosis
- Exploiting Nanotechnology
- Key Challenges Faced by the Industry
- Issues of Reimbursement
- More Approvals for Tracer Agents
- Company Profi les
- GE Healthcare
- Siemens Medical Solutions
- Philips Medical Systems
- Outlook
- Appendix A. Imaging Agents in Clinical Development
Tables
- 1. Advantages and Disadvantages of Major Diagnostic Imaging Modalities
- 2. Select 99mTc Radiopharmaceuticals in Clinical Application
- 3. Diagnostic Imaging Collaborations of GE Healthcare, 2000-Present
- 4. Diagnostic Imaging Collaborations of Siemens Medical Solutions,
2000-Present
- 5. Diagnostic Imaging Collaborations of Philips Medical Systems,
2000-Present
- 6. Trends That Companies Should Heed for Future Success
Figures
- 1. The U.S. Diagnostic Imaging Market, 2005-2011
- 2. Market Value of Major Diagnostic Imaging Modalities, United States,
2005-2011
- 3. Clinical Applications of Diagnostic Imaging Techniques
- 4. Worldwide Revenues for Imaging Agents, 2007-2012
- 5. Leading Companies in the U.S. Diagnostic Imaging Market, 2006
- 6. Comparison of Leading Companies by Diagnostic Imaging Modality, United
States, 2006
|
